iShares China Large-Cap ETF (FXI)

Key Updates

FXI declined 2.02% to $35.59 since the June 2 report, erasing the prior session's gains and confirming the volatile trading pattern that has characterized Chinese equities throughout May. The 2.13% single-day decline represents the sharpest intraday loss since the regulatory crackdown announcement in late May. YTD losses now stand at -7.06%, while the 6-month performance shows a more pronounced -9.25% decline, indicating persistent structural headwinds despite intermittent diplomatic optimism. The current price action suggests investors remain cautious about sustained exposure to Chinese large-caps, with capital flows proving highly sentiment-driven rather than fundamentally anchored.

Current Trend

FXI remains in a downtrend across all meaningful timeframes, with YTD losses of -7.06% and 6-month declines of -9.25% establishing clear resistance at the $36-$37 level. The ETF has failed to sustain momentum above $36 despite three attempts in the past week, with the current $35.59 level representing a 2.13% single-day retreat. Short-term volatility remains elevated, evidenced by the 5-day performance of +0.75% masking significant intraday swings. The 1-month decline of -2.64% confirms the medium-term negative trajectory. Trading patterns show rapid rallies followed by equally swift reversals, indicating fragile investor conviction and suggesting the ETF lacks the fundamental support necessary for a sustained recovery toward the $38-$40 range last seen in early 2026.

Investment Thesis

The investment thesis for FXI centers on China's economic stabilization, attractive valuations at 11x 2027 earnings (half of U.S. multiples), and expected earnings growth of 15% matching American levels according to Goldman Sachs data. The $20 trillion economy has moved past its property crisis and maintained record trade surpluses of $1.2 trillion in 2025. Technology sector strength represents a key pillar, with AI-focused revenue growth exemplified by Baidu's 49% surge to 13.6 billion yuan and Zhipu's 132% revenue expansion, as highlighted by UBS's bullish positioning. Improved U.S.-China relations following the Trump-Xi summit and potential tariff reductions on $30 billion in goods provide diplomatic tailwinds. However, the thesis faces material challenges from Beijing's capital control intensification, evidenced by the regulatory crackdown on cross-border brokerages, and foreign direct investment remaining at $80 billion in 2025—significantly below the $344 billion 2021 peak.

Thesis Status

The investment thesis faces increasing headwinds that outweigh near-term catalysts. While valuations remain compelling and earnings growth projections are intact, the regulatory environment has deteriorated materially since the last report. Beijing's aggressive enforcement against Futu Holdings, Up Fintech, and Longbridge Securities for facilitating overseas stock access signals a fundamental shift toward capital containment rather than liberalization. This directly contradicts the thesis assumption of improving market accessibility and investor confidence. The Trump-Xi summit produced minimal concrete outcomes beyond cautious optimism, with Xi's Taiwan warnings reintroducing geopolitical risk. Morgan Stanley's 8-12% upside targets through 2Q 2027 appear increasingly optimistic given the current -7.06% YTD performance and persistent selling pressure. The thesis requires recalibration to account for structural capital flow restrictions that may permanently cap foreign participation regardless of valuation attractiveness or earnings growth.

Key Drivers

China's regulatory crackdown on cross-border brokerages represents the most significant negative catalyst, with mandatory liquidation of mainland accounts within two years signaling Beijing's determination to prevent capital outflows. This enforcement action resulted in 25-28% declines for affected brokerages and undermines investor confidence in market accessibility. Improved U.S.-China diplomatic relations following the Trump-Xi summit provided temporary support, with China and Hong Kong ETFs receiving $1.22 billion in inflows immediately following the meeting. However, the summit produced few concrete outcomes, with potential tariff reductions on only $30 billion in goods representing just 10% of China's U.S. exports. Technology sector strength continues, with UBS highlighting China's expanding AI ecosystem and strong earnings growth in AI-focused businesses. Yuan appreciation to 6.784 against the dollar—its strongest level since 2023—provides currency tailwinds but also reflects capital control effectiveness rather than organic strength.

Technical Analysis

FXI is trading at $35.59, establishing a clear resistance zone between $36.00-$36.50 that has rejected three breakout attempts in the past week. The 2.13% single-day decline represents a decisive rejection from the $36.32 level reached on June 2, confirming seller dominance at these levels. Support appears tentative at $35.00-$35.50, with a break below potentially targeting the $34.70 level from the May 28 report. The 5-day performance of +0.75% masks significant intraday volatility, indicating choppy, range-bound trading rather than directional conviction. Volume patterns suggest institutional distribution during rallies, consistent with the broader trend of foreign investors prioritizing liquidity and exit opportunities. The 6-month decline of -9.25% versus the 1-month decline of -2.64% indicates selling pressure has moderated but not reversed. Price action remains characterized by sharp 2-3% rallies followed by equivalent or larger declines, creating a descending triangle pattern with lower highs since the October 2025 peaks mentioned in the May 12 analysis showing FXI down 11% from those levels.

Bull Case

• Attractive valuations at 11x 2027 forecast earnings—approximately half of U.S. equity multiples—combined with expected earnings growth of 15% matching American levels, creating compelling risk-reward for value-oriented investors willing to accept volatility, per Goldman Sachs analysis
• Strong AI ecosystem development with Baidu reporting 49% revenue surge in AI-focused business to 13.6 billion yuan and Zhipu achieving 132% revenue growth in 2025, positioning Chinese tech companies for sustained earnings expansion as highlighted by UBS's bullish stance
• Morgan Stanley's upgraded price targets projecting 8-12% upside through 2Q 2027 across major Chinese indexes, supported by improved earnings, strengthening position in global upstream supply chains, and yuan appreciation, as detailed in their May 13 research
• Post-summit capital flows showing $1.22 billion in inflows to China and Hong Kong ETFs, demonstrating institutional investors are actively adding exposure following diplomatic progress between Trump and Xi, per Bloomberg's May 19 reporting
• Economic stabilization with China moving past its property crisis while maintaining record trade surpluses of $1.2 trillion in 2025, creating a more stable foundation for equity appreciation than the crisis-plagued 2022-2024 period, according to Reuters analysis

Bear Case

• Beijing's aggressive regulatory crackdown on cross-border brokerages—confiscating all illegal gains from Futu Holdings, Up Fintech, and Longbridge Securities while mandating 2-year account liquidations—signals intensifying capital controls that fundamentally restrict foreign investor access and market liquidity, as detailed in Bloomberg's May 26 analysis
• Foreign direct investment collapsed to $80 billion in 2025 from the $344 billion peak in 2021, demonstrating sustained capital flight and deteriorating investor confidence that valuation discounts alone cannot overcome, per Reuters reporting
• Trump-Xi summit produced minimal concrete outcomes with potential tariff reductions limited to approximately $30 billion in goods—only 10% of China's U.S. exports—while Xi's Taiwan warnings reintroduced geopolitical risk that triggered immediate market selloffs, as covered in Bloomberg's May 14 report
• Persistent downtrend across all timeframes with YTD losses of -7.06%, 6-month declines of -9.25%, and FXI down 11% from October highs, establishing clear technical resistance at $36-$37 that has rejected multiple breakout attempts, according to CNBC's May 12 technical analysis
• Technology sector selloffs with ChiNext and STAR 50 indexes falling 2.5-2.6% following profit-taking, while the broader regulatory environment creates uncertainty around Beijing's tolerance for tech sector growth that could conflict with state control objectives, per Bloomberg's summit coverage